Cui R - Search Results

1

Hepatitis B Virus X Protein Modulates Chemokine CCL15 Upregulation in Hepatocellular Carcinoma.

Li Y, Wang C, Zhao T, Cui R, Hu L, Chang L, Wei X, Zhang J, Li Y. Li Y, et al. Among authors: cui r. Anticancer Agents Med Chem. 2021 Oct 28;21(16):2198-2203. doi: 10.2174/1871520621666210302083407. Anticancer Agents Med Chem. 2021. PMID: 33653254

2

Role of Carboxypeptidase N Invasion and Migration in Breast Cancer.

Cui R, Zhang P, Li Y. Cui R, et al. Anticancer Agents Med Chem. 2016;16(9):1198-202. doi: 10.2174/1871520616666160201104939. Anticancer Agents Med Chem. 2016. PMID: 26860443

3

Prediction of Lymph Node Metastases in Gastric Cancer by Serum APE1 Expression.

Wei X, Li YB, Li Y, Lin BC, Shen XM, Cui RL, Gu YJ, Gao M, Li YG, Zhang S. Wei X, et al. J Cancer. 2017 Jun 1;8(8):1492-1497. doi: 10.7150/jca.18615. eCollection 2017. J Cancer. 2017. PMID: 28638465 Free PMC article.

4

Clinical value of ROMA index in diagnosis of ovarian cancer: meta-analysis.

Cui R, Wang Y, Li Y, Li Y. Cui R, et al. Cancer Manag Res. 2019 Mar 28;11:2545-2551. doi: 10.2147/CMAR.S199400. eCollection 2019. Cancer Manag Res. 2019. PMID: 30992682 Free PMC article.

5

Hypoxia-Induced TGFBI as a Serum Biomarker for Laboratory Diagnosis and Prognosis in Patients with Pancreatic Ductal Adenocarcinoma.

Yang L, Cui R, Li Y, Liang K, Ni M, Gu Y. Yang L, et al. Among authors: cui r. Lab Med. 2020 Jul 8;51(4):352-361. doi: 10.1093/labmed/lmz063. Lab Med. 2020. PMID: 31626700

6

Serum Carboxypeptidase N1 Serves as a Potential Biomarker Complementing CA15-3 for Breast Cancer.

Cui R, Wang C, Zhao Q, Wang Y, Li Y. Cui R, et al. Anticancer Agents Med Chem. 2020;20(17):2053-2065. doi: 10.2174/1871520620666200703191135. Anticancer Agents Med Chem. 2020. PMID: 32619179

7

Carboxypeptidase N1 is anticipated to be a synergy metrics for chemotherapy effectiveness and prognostic significance in invasive breast cancer.

Cui R, Wang C, Li T, Hua J, Zhao T, Ren L, Wang Y, Li Y. Cui R, et al. Cancer Cell Int. 2021 Oct 28;21(1):571. doi: 10.1186/s12935-021-02256-5. Cancer Cell Int. 2021. PMID: 34711246 Free PMC article.

8

High Expression of RAI14 in Triple-Negative Breast Cancer Participates in Immune Recruitment and Implies Poor Prognosis Through Bioinformatics Analyses.

Cui R, Zhao T, Bai C, Ji N, Hua J, Ren L, Li Y. Cui R, et al. Front Pharmacol. 2022 Apr 1;13:809454. doi: 10.3389/fphar.2022.809454. eCollection 2022. Front Pharmacol. 2022. PMID: 35431930 Free PMC article.

9

The dual-crosslinked prospective values of RAI14 for the diagnosis and chemosurveillance in triple negative breast cancer.

Cui R, Zou J, Zhao Y, Zhao T, Ren L, Li Y. Cui R, et al. Ann Med. 2023 Dec;55(1):820-836. doi: 10.1080/07853890.2023.2177722. Ann Med. 2023. PMID: 36880986 Free PMC article.

10

Tumor-derived CCL15 regulates RNA m⁶A methylation in cancer-associated fibroblasts to promote hepatocellular carcinoma growth.

Wang C, Dong D, Zhao N, Liu Y, Bai C, Hua J, Cui R, Wei X, Zhao T, Ji N, Yang S, Zhao J, Li H, Li Y. Wang C, et al. Among authors: cui r. Cancer Lett. 2024 Dec 27;611:217420. doi: 10.1016/j.canlet.2024.217420. Online ahead of print. Cancer Lett. 2024. PMID: 39734010

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,927 results

Search Page

Filters